Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial (Q34275637)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial |
scientific article |
Statements
1 reference
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial (English)
1 reference
Jan Wehkamp
1 reference
Brian G Feagan
1 reference
Bruce E Sands
1 reference
Walter Reinisch
1 reference
Wolfgang Hueber
1 reference
Steve Lewitzky
1 reference
Marc Vandemeulebroecke
1 reference
Peter D R Higgins
1 reference
Michael D Yao
1 reference
Marek Karczewski
1 reference
Jacek Karczewski
1 reference
Nicole Pezous
1 reference
Stephan Bek
1 reference
Gerard Bruin
1 reference
Bjoern Mellgard
1 reference
Claudia Berger
1 reference
Marco Londei
1 reference
Arthur P Bertolino
1 reference
Gervais Tougas
1 reference
Simon P L Travis
1 reference
Secukinumab in Crohn's Disease Study Group
1 reference
17 May 2012
1 reference
1 reference
61
1 reference
12
1 reference
1693-1700
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference